Status:
COMPLETED
Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
End Stage Renal Disease
ESRD
Eligibility:
All Genders
19+ years
Brief Summary
This study, done in collaboration with Johns Hopkins University School of Public Health in Baltimore, Maryland, will examine the role of genes in the development of atherosclerotic cardiovascular dise...
Detailed Description
Background: The CHOICE (Choices for Healthy Outcomes in Caring for End stage renal disease) study is a national prospective cohort study of 1,041 incident dialysis patients aged 19 to 95 recruited in...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Original eligibility criteria for enrollment in the CHOICE cohort included: 1) new onset of chronic outpatient renal replacement therapy in the last 3 months, 2) ability to give informed consent to participate in the study, 3) age 19 years or older, 4) ability to speak English or Spanish.
- EXCLUSION CRITERIA:
- The entire set of 871 samples available to the LGD will be analyzed. No subject will be excluded.
Exclusion
Key Trial Info
Start Date :
March 21 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
871 Patients enrolled
Trial Details
Trial ID
NCT00340119
Start Date
March 21 2005
End Date
March 1 2012
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205